Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 441

1.

Update on cytokines in rheumatoid arthritis.

Brennan F, Beech J.

Curr Opin Rheumatol. 2007 May;19(3):296-301. Review.

PMID:
17414959
[PubMed - indexed for MEDLINE]
2.

Emerging cytokine targets in rheumatoid arthritis.

Asquith DL, McInnes IB.

Curr Opin Rheumatol. 2007 May;19(3):246-51. Review.

PMID:
17414950
[PubMed - indexed for MEDLINE]
3.

The role of T cells in rheumatoid arthritis: new subsets and new targets.

Toh ML, Miossec P.

Curr Opin Rheumatol. 2007 May;19(3):284-8. Review.

PMID:
17414957
[PubMed - indexed for MEDLINE]
4.

Novel pro-inflammatory interleukins: potential therapeutic targets in rheumatoid arthritis.

Bessis N, Boissier MC.

Joint Bone Spine. 2001 Dec;68(6):477-81. Review.

PMID:
11808983
[PubMed - indexed for MEDLINE]
5.

Macrophages and their products in rheumatoid arthritis.

Szekanecz Z, Koch AE.

Curr Opin Rheumatol. 2007 May;19(3):289-95. Review.

PMID:
17414958
[PubMed - indexed for MEDLINE]
6.

Rheumatoid arthritis and interleukin-32.

Shoda H, Fujio K, Yamamoto K.

Cell Mol Life Sci. 2007 Oct;64(19-20):2671-9. Review.

PMID:
17619821
[PubMed - indexed for MEDLINE]
7.

Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.

Sheibanie AF, Khayrullina T, Safadi FF, Ganea D.

Arthritis Rheum. 2007 Aug;56(8):2608-19.

PMID:
17665454
[PubMed - indexed for MEDLINE]
Free Article
8.

An update on the cytokine network in rheumatoid arthritis.

Miossec P.

Curr Opin Rheumatol. 2004 May;16(3):218-22. Review.

PMID:
15103248
[PubMed - indexed for MEDLINE]
9.

Cytokines in rheumatoid arthritis: is it all TNF-alpha?

Miossec P.

Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):675-8. Review.

PMID:
11502074
[PubMed - indexed for MEDLINE]
10.

Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations.

Hussein MR, Fathi NA, El-Din AM, Hassan HI, Abdullah F, Al-Hakeem E, Backer EA.

Pathol Oncol Res. 2008 Sep;14(3):321-8. doi: 10.1007/s12253-008-9016-1. Epub 2008 Apr 8.

PMID:
18392953
[PubMed - indexed for MEDLINE]
11.

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.

Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, Finckh A, Smith DE, Gabay C.

Arthritis Rheum. 2009 Mar;60(3):738-49. doi: 10.1002/art.24305.

PMID:
19248109
[PubMed - indexed for MEDLINE]
Free Article
12.

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.

Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M.

APMIS. 1997 Apr;105(4):257-63. Review.

PMID:
9164467
[PubMed - indexed for MEDLINE]
13.

IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

Lubberts E.

Cytokine. 2008 Feb;41(2):84-91. Epub 2007 Nov 26. Review.

PMID:
18039580
[PubMed - indexed for MEDLINE]
14.

Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.

McInnes IB, Gracie JA.

Curr Pain Headache Rep. 2005 Dec;9(6):405-11. Review.

PMID:
16282041
[PubMed - indexed for MEDLINE]
15.

Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.

Lee JD, Huh JE, Jeon G, Yang HR, Woo HS, Choi DY, Park DS.

Int Immunopharmacol. 2009 Mar;9(3):268-76. doi: 10.1016/j.intimp.2008.11.005. Epub 2008 Dec 25.

PMID:
19111632
[PubMed - indexed for MEDLINE]
16.

[Cytokines and their antagonists in the treatment of rheumatoid arthritis].

Klimiuk PA, Sierakowski S.

Przegl Lek. 2002;59(2):108-12. Review. Polish.

PMID:
12152246
[PubMed - indexed for MEDLINE]
17.

Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.

Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, Mikecz K, Glant TT.

Arthritis Rheum. 2008 Aug;58(8):2397-408. doi: 10.1002/art.23653.

PMID:
18668542
[PubMed - indexed for MEDLINE]
Free Article
18.

IL-17 as a future therapeutic target for rheumatoid arthritis.

van den Berg WB, Miossec P.

Nat Rev Rheumatol. 2009 Oct;5(10):549-53. doi: 10.1038/nrrheum.2009.179. Review.

PMID:
19798029
[PubMed - indexed for MEDLINE]
19.

IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.

Leng RX, Pan HF, Tao JH, Ye DQ.

Expert Opin Ther Targets. 2011 Feb;15(2):119-26. doi: 10.1517/14728222.2011.534461. Epub 2010 Nov 12. Review.

PMID:
21073280
[PubMed - indexed for MEDLINE]
20.

Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma.

Kelchtermans H, Schurgers E, Geboes L, Mitera T, Van Damme J, Van Snick J, Uyttenhove C, Matthys P.

Arthritis Res Ther. 2009;11(4):R122. doi: 10.1186/ar2787. Epub 2009 Aug 17.

PMID:
19686583
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk